UK Professor of Pharmacology and Nutritional Sciences Nancy Webb, Ph.D., has been honored by the American Heart Association with the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Distinguished Achievement Award.
The University of Kentucky Center for Appalachian Research in Environmental Sciences (UK-CARES) is now accepting applications from full-time early stage investigators at the University of Kentucky (UK) for the Career Development Program.
Lance Cpl. Benjamin Shaw is currently in his fourth year of the UK College of Medicine’s PhD program in physiology, studying the effect genetic differences have on immune cell function related to Alzheimer’s disease risk.
ValidCare, the hemp industry’s leading market intelligence and consumer research platform, and the UK Research Foundation (UKRF) have announced they have entered into a services agreement to advance the research of hemp-derived products.
The Justice Community Opioid Innovation Network (JCOIN) supports research on quality addiction treatment for OUD in criminal justice settings nationwide.
A unique partnership between an engineer and a scientist at UK has produced data that is challenging prevailing wisdom about a potentially fatal parasite.
UK received $8.8 million from NIDA as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on addiction treatment for opioid use disorder in criminal justice settings nationwide.
The world of pediatric cancer treatment has seen huge advancements in treatments over the past 60 years – in the 1950s, less than 10 percent of children were cured of their cancer. Today, the number of survivors is nearly 80 percent.
New research at UK has confirmed that the presence of XX sex chromosomes increases the amount of fat circulating in the blood, which leads to narrowing of the arteries and ultimately a higher risk of heart attacks and coronary artery disease.